China Strategic Technology Group Limited (China Strategic Tech) announced that its non-wholly owned subsidiary, CT Vessel, signed a series of agreements and memoranda of understanding on 20 June 2026 with partners spanning the United States, Malaysia, Africa and mainland China.
The counterparties include the China-Africa Economic and Trade Investment Promotion Association, Tokheim Hengshan Technology (Guangzhou) Co., Namin Trading Sdn. Bhd., Guangxi Beihai Chaoyang Real Estate Development, Guangxi Tongtonglai Business Information Consulting, Shenzhen Wosai Life Data Technology, Guangxi Tianwei Jing Shipping, Guangxi Nuoxun Trading and Gongneng Zongbu Technology (Guangdong).
Key cooperation areas: • Technical collaboration on new-energy intelligent vessel development • Agency and distribution arrangements for sales expansion • Establishment of CT Vessel 6S (sales and service) outlets • Joint market-promotion initiatives and channel building in domestic and overseas regions, with a focus on Guangxi’s key waterways and selected overseas markets • Exploration of localised manufacturing opportunities outside China
Management expects the framework to accelerate CT Vessel’s market penetration by enlarging its sales channels, service network and regional coverage. Further, the agreements aim to enhance end-user support capabilities and deepen the Group’s presence in the new-energy vessel segment.
The Group cautions that specific project details, implementation timetables and final outcomes remain subject to subsequent negotiations, market conditions and fulfilment of agreed conditions. As such, immediate financial impact on the Group is not anticipated.
Company background: • Core businesses: aerospace titanium alloy materials, satellite component production, digital satellite applications, unmanned spacecraft R&D, precision manufacturing, EMS/PCBA, energy and thermal management systems, and industrial sensor production. • Emerging segments: CT Vessel (new-energy small commercial and civilian vessels) and CT Biotechnology (life engineering and biomedicine).
China Strategic Tech emphasizes that shareholders and potential investors should exercise caution when dealing in its shares, given the preliminary nature of the cooperation framework.
Comments